APOE and early-onset autosomal dominant Alzheimer disease: A similar model for Alzheimer’s disease (AD) is the PrecivityAD test for beta-amyloid and for Apo E isoform-specific prototyping, which has been approved by the FDA as a screening test to assist in identifying relative risk of AD and in selecting patients for expensive 18F-florbetapir scans [37].